(Q44389242)

English

The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure

scientific article published in April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure (English)

1 reference

Europe PubMed Central

2 December 2017

Alzheimer's disease

0 references

0 references

author name string

Mintzer JE

1

1 reference

Europe PubMed Central

2 December 2017

Kershaw P

2

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

2 December 2017

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

2 December 2017

18

1 reference

Europe PubMed Central

2 December 2017

4

1 reference

Europe PubMed Central

2 December 2017

292-297

1 reference

Europe PubMed Central

2 December 2017

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

1 reference

https://api.crossref.org/works/10.1002%2FGPS.826

21 January 2018

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.826

21 January 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1002%2FGPS.826

21 January 2018

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.826

21 January 2018

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.826

21 January 2018

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1 reference

https://api.crossref.org/works/10.1002%2FGPS.826

7 January 2021

based on heuristic

inferred from DOI database lookup

The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.826

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.826

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.826

1 reference

Europe PubMed Central

2 December 2017

release_mi27cdewvvffxesv65swicmzwi

1 reference

https://api.fatcat.wiki/v0/release/mi27cdewvvffxesv65swicmzwi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44389242&oldid=2020794107"